Back to WELLINGTON MANAGEMENT GROUP LLP WELLINGTON MANAGEMENT GROUP LLP

DNTHDNTH
8 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLPWELLINGTON MANAGEMENT GROUP LLP's holdings in Dianthus Therapeutics, Inc.

WELLINGTON MANAGEMENT GROUP LLP holds 3.2M shares of DNTH (Dianthus Therapeutics, Inc.), worth $314.8M as of 2026-Q2. The position was increased (+24.4% shares). DNTH represents 0.1% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.

Current Value

$314.8M

Current Shares

3.2M

Total Value Change

+$313.4M

Total Shares Change

+3.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.2M
+24.4%
$314.8M0.1%$97.48
38
2026-Q1
Increased
2.6M
+3.7%
$217.8M0.0%$55.39
32
2025-Q4
Decreased
2.5M
-2.9%
$103.2M0.0%$40.96
0
2025-Q3
Increased
2.6M
+3366.9%
$101.4M0.0%$39.55
48
2025-Q2
Increased
74,351
+9.4%
$1.4M0.0%$17.63
28
2025-Q1
Increased
67,982
+12.7%
$1.2M0.0%$19.99
28
2024-Q4
Increased
60,337
+12.2%
$1.3M0.0%$21.50
28
2024-Q3
New
53,785
-
$1.5M0.0%$27.24
35

Other major holders of DNTH: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used